CB - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 79275433
Serial Number
79275433
Registration Number
6110252
Word Mark
CB
Status
700 - Registered
Status Date
2020-07-28
Filing Date
2019-11-18
Registration Number
6110252
Registration Date
2020-07-28
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
260106, 261710 - Semi-circles. Zig-zag line(s).
Published for Opposition Date
2020-05-12
Attorney Name
Maury M. Tepper, III
Law Office Assigned Location Code
L40
Employee Name
FATHY, DOMINIC
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of the intertwined letters "CB".
Goods and Services
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Pseudo Mark
C B
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-01-08
Primary Code
005
Current Trademark Owners
Party Name
NOVARTIS AG
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (aktiengesellschaft).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
NOVARTIS AG
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (aktiengesellschaft).
Address
Please log in with your Justia account to see this address.
Party Name
NOVARTIS AG
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (aktiengesellschaft).
Address
Please log in with your Justia account to see this address.
Party Name
NOVARTIS AG
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (aktiengesellschaft).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Maury M. Tepper, III
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1506617
International Registration Date
2019-11-18
International Publication Date
2020-01-02
International Renewal Date
2029-11-18
Auto Protection Date
2021-11-14
International Status
001 - Request for extension of protection established
International Status Date
2020-01-02
Priority Claimed In
True
Priority Claimed Date
2019-11-12
First Refusal In
True
Trademark Events
Event DateEvent Description
2020-01-02SN ASSIGNED FOR SECT 66A APPL FROM IB
2020-01-02LIMITATION FROM ORIGINAL APPLICATION ENTERED
2020-01-08NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2020-01-14APPLICATION FILING RECEIPT MAILED
2020-02-04ASSIGNED TO EXAMINER
2020-02-07NON-FINAL ACTION WRITTEN
2020-02-08NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2020-03-03REFUSAL PROCESSED BY MPU
2020-03-03NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2020-03-09TEAS CHANGE OF OWNER ADDRESS RECEIVED
2020-03-09TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2020-03-09ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2020-03-09TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
2020-03-09TEAS CHANGE OF CORRESPONDENCE RECEIVED
2020-03-09APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2020-03-12TEAS RESPONSE TO OFFICE ACTION RECEIVED
2020-03-12CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-03-13TEAS/EMAIL CORRESPONDENCE ENTERED
2020-03-21REFUSAL PROCESSED BY IB
2020-03-26APPROVED FOR PUB - PRINCIPAL REGISTER
2020-04-22NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2020-05-12PUBLISHED FOR OPPOSITION
2020-05-12OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2020-05-15CORRECTION TRANSACTION RECEIVED FROM IB
2020-05-28CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
2020-07-28REGISTERED-PRINCIPAL REGISTER
2020-10-28FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2020-11-17FINAL DISPOSITION PROCESSED
2020-11-17FINAL DISPOSITION NOTICE SENT TO IB
2020-12-06FINAL DECISION TRANSACTION PROCESSED BY IB